TIDMGSK

RNS Number : 4041Q

GlaxoSmithKline PLC

18 June 2020

   GlaxoSmithKline plc   (the ' Company ') 

Transaction notification

 
 1.    Details of PDMR/person closely associated with them ('PCA') 
====  ============================================================================================== 
 a)    Name                                     Ms D Waterhouse 
====  ========================================  ==================================================== 
 b)    Position/status                          CEO of ViiV Healthcare 
====  ========================================  ==================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ==================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================== 
 a)    Description of                           Ordinary shares of 25 pence each ('Ordinary 
        the financial                            Shares') 
        instrument                               ISIN: GB0009252882 
====  ========================================  ==================================================== 
 b)    Nature of the                            Following the final vesting on 15 June 
        transaction                              2020 of an award made on 15 June 2017 under 
                                                 the GlaxoSmithKline Deferred Investment 
                                                 Award programme, Ms Waterhouse will receive 
                                                 a cash payment of GBP75,564.47 less applicable 
                                                 tax withholding in respect of 4,720.419 
                                                 notional Ordinary Shares. 
====  ========================================  ==================================================== 
 c)    Price(s) and                              Price(s)                Volume(s) 
        volume(s) 
====  ========================================   ======================  ========================= 
                                                 16.008                  4,720.419 
                                                 ======================  ========================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =========================================  ======================================================== 
 e)    Date of the transaction                  2020-06-15 
====  ========================================  ==================================================== 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  ==================================================== 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHFVLFFBQLLBBX

(END) Dow Jones Newswires

June 18, 2020 07:25 ET (11:25 GMT)

Grafico Azioni Gsk (LSE:GSK)
Storico
Da Feb 2024 a Mar 2024 Clicca qui per i Grafici di Gsk
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Mar 2023 a Mar 2024 Clicca qui per i Grafici di Gsk